On LINC 2016, Dr. Teichgraber presented the results of the study using Angiodroid along with the new acquisition and post processing protocol developed by Siemens, the Even Flow CO2 Protocol.
The results were very bright and promising!
We want especially to thank Dr. Teichgraber for having conducted a highly future-oriented study of CO2 angiography and for the patients benefit.
We are sorry, you can access this content only if you are an Healthcare Professionist.
Angiodroid adopted this restrictions in accordance with the Italian regulations on sponsorship of medical devies (art. 21 of D.L. 24.02.97, n.46; 93/42/CEE directive; guidelines 17.02.2010)